This week BioPact sponsored and attended the 5th annual American Drug Delivery and Formulation Summit in Costa Mesa, CA. This event provides a comprehensive overview of the most exciting innovations in drug delivery and an opportunity for companies with novel drug delivery technologies to connect with potential, buyers. “Our message is simple”, said CEO […]
BioPact appoints new Vice President of Business Development
Fast Growing Company Secures Top Talent for Product Launch Initiative
Cambridge, MA – BioPact (company.bio-pact.com) announced that Lainie Mulvanny has joined the company to lead and support the organization’s much-anticipated launch of their research and development kits. Mulvanny brings a wealth of industry experience from positions held at […]
BioPact CEO Kent Phelps presents at UMass as finalist in the 2015 M2D2 New Venture Competition
On April 1st, M2D2 held a live pitch-off event featuring 15 early-stage medical companies vying for $100,000 in prizes. The international competition showcased ideas from young medical device companies and will provide winners with mentorship and funding. The audience […]
On April 1, 2015, M2D2 will hold a live pitch-off event featuring 15 early-stage medical companies vying for $100,000 in prizes. The international competition will showcase ideas from young medical device companies and will provide winners with mentorship and funding. Investors, inventors, start-ups, physicians and business professionals will be in attendance at the event […]
In January’s look at the life sciences industry in Massachusetts, the talk is focused on new companies arriving in the state, new mergers, acquisitions and upcoming projects. Angus McQuilken, vice president at the Massachusetts Life Sciences Center, joined NECN to discuss the latest happenings taking place in the industry. A young company from Arizona […]
BIOPACT CEO KENT PHELPS PRESENTS IN SAN FRANCISCO AT ONEMEDFORUM DURING THE JP MORGAN ANNUAL HEALTHCARE CONFERENCE
BioPact CEO Kent Phelps presents in San Francisco at OneMedForum during the JP Morgan Annual Healthcare Conference
CEO Kent Phelps presented information about Medical Grade Molecular Rebar, or MGMR, BioPact’s first of its kind new composition of matter that represents the re-birth of the carbon nanotube, to biopharm industry insiders and investors at OneMedForum during […]
The medical grade carbon nanotube manufacturer and developer is moving it’s corporate headquarters to Cambridge. According to a press release, Governor Deval Patrick met with BioPact last June, hoping to bring the company to Massachusetts and pushing Massachusetts even closer to being the world’s leading life science ecosystem. BioPact also works on projects in […]
BioPact, an eight-month-old Arizona company that applies recent breakthroughs on carbon nanotube technology to the life sciences, has decided to move its corporate headquarters to Kendall Square.
Visit Http://www.bizjournals.com/boston/blog/bioflash/2015/01/carbon-nanotube-maker-bio-pact-moves-hq-from.html to view the full story.
BioPact, LLC, announced today that the company is moving its corporate headquarters to Massachusetts, which will be located at 245 First Street in Cambridge. Governor Deval Patrick met with BioPact at the BIO Convention in San Diego last June to share the incredible strengths of Massachusetts as the world’s leading life sciences ecosystem.